TMCnet News
Great News From Stock Marketing Inc.!! Sign Up Today!! AMEL,DGDM,CBAI,UVFT,BONU,DTRO(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (OTCBB: AMEL) Amerilithium Corp., (OTCBB: DGDM) Digital Development Partners, Inc., (OTCBB: CBAI) Cord Blood America, Inc., (OTCBB: UVFT) UV Flu Technologies, Inc., (OTCBB: BONU) BioNeutral Group, Inc., (OTCBB: DTRO) Deltron, Inc. www.StockMarketingInc.com For More Information email us!! [email protected] ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: AMEL - Amerilithium Corp.) LATEST NEWS!! AmeriLithium Receives $500,000 Draw Down on $10,000,000 Finance Agreement to Accelerate Domestic Exploration LAKE TAHOE, NV, June 16, 2010 -- AmeriLithium (OTC Bulletin Board: AMEL) is pleased to announce the Company received its third draw down from its $10 million finance agreement on June 10, 2010. The purpose of the $500,000 draw is to fund the Company's next stages of Lithium exploration on its Nevada-based Paymaster Project, having received positive results from the property's gravity survey in early June 2010. The gravity survey identified three significant bedrock elevation lows on the Company's property that warrant further exploration. Each will be tested during the next phase of geophysical exploration, which will begin within the next few weeks, making use of Controlled Source Audiomagnegtotellurics / Magnetotellurics (CSAM/MT), a geophysical technique commonly utilized in mineral exploration to provide deep geologic information. AmeriLithium's domestic Paymaster Project represents a 5,880-acre claim block adjacent to the Clayton Valley playa, where lithium-rich brines and evaporates have been accumulating for more than 30,000 years, resulting in the highest lithium content found in any brines tested by the US Geological Survey (USGS) in southwestern US playas and basins.(1) Clayton Valley is home to the only US-based lithium producing plant, operated by neighboring Chemetall Foote Corporation, a subsidiary of Rockwood Holdings, Inc. The plant has been in production since 1967, producing an estimated 50 million kg (55,000+ tons) of lithium to date from the region's rich brines.(2) "With the demand for Lithium growing, especially from the electronics and electric vehicle markets, our Paymaster Project exploration program becomes more critical every day," said Matthew Worrall, AmeriLithium's CEO. "And now that it's time to move on to our second exploration phase, we're fortunate to have the backing of this third draw down on our financing agreement so we can remain focused on our domestic exploration in a strategic and efficient manner while keeping in mind our overall goal of AmeriLithium establishing itself as a major player in the Lithium production and supply market." FOR MORE INFORMATION More information on the financing agreement and the Paymaster exploration program, and additional information regarding the Company, can be found at AmeriLithium's corporate website www.amerilithium.com along with the facility to sign up for regular news updates. ABOUT LITHIUM: Lithium is a lightweight metal used in a wide range of consumer products the world over: the medical industry uses lithium as an anti-depressant; industrial uses include glass, ceramic and porcelain enamel manufacture; the aviation industry uses lithium in alloys. Of particular interest is the use of lithium for battery production, which has expanded significantly in recent years due to rechargeable lithium batteries being used increasingly in electrical tools and in the rapidly expanding portable electronics market. Furthermore, the next generation of hybrid and electric vehicles are being designed to use high-capacity lithium-ion batteries as environmentally-friendly fuel alternatives while the Obama administration has introduced $5 billion in funding and incentives for the development of a secure, domestic battery industry with special focus on lithium-ion batteries. ABOUT AMERILITHIUM: AmeriLithium is a publicly traded (OTCBB: AMEL), mining company committed to progressively developing into one of the leading American players in the global lithium industry. The Company is headquartered in Lake Tahoe, NV. AmeriLithium has amassed a lithium portfolio consisting of ~724,000 acres, including three Nevada-based projects nearby the only lithium producing plant in the US, a large project in Alberta, Canada, and a project in Western Australia. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: DGDM - Digital Development Partners, Inc.) LATEST NEWS!! Digital Receives LOI for 2 Million Dollar Back Up Line of Credit CITY OF INDUSTRY, Calif., Jun 16, 2010 -- Digital Development Partners, Inc., (OTCBB: DGDM) the exclusive distributer and servicing provider for the EFT-Smartphone, announced today that it has received from its majority owner a letter of intent to provide a working line of credit if needed of up to 2 million dollars. As announced earlier Digital is scheduled to deliver its first shipment of Smartphones to EFT International by the end of June. Digital received its first order of 100,000 Smartphones in May 2010 which, when fully delivered, should generate over twenty million dollars in revenues for the company excluding servicing fees and accessories. Jack Qin, Chairman and CEO, stated, "The working line of credit will reassure the investors in our stock and our service subscribers that we will have access to cash should we need it to continue the build-out of our network and service centers throughout China and Southeast Asia. Our primary goal of 100,000 Smartphones, we feel will be reached with only obtaining a 10% penetration rate of the over 1 million EFT registered affiliates. We also plan to offer the EFT-Smartphone to other organizations like EFT which have a large number of end-user customers." About Digital Digital plans to distribute and service the EFT Mobile PDA Smartphone to EFT's base of affiliated members throughout Asia. The unique aspect of the EFT-Smartphone is that EFT affiliates will be able to speak with all other affiliates at no charge while in a Wi-Fi location utilizing VoIP technology. Another unique aspect is the additional Apps that will allow the EFT affiliate base to access all their back office sites including their Funds Management Account where the affiliate will be able to deposit funds to make purchases, withdraw and transfer money to another EFT account or to another EFT affiliate at no cost for the internal transfer. The EFT-Smartphone will have educational applications and PowerPoint presentations for recruiting and training new affiliate members anywhere in the world. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: CBAI - Cord Blood America, Inc.) LATEST NEWS!! Cord Blood America Spokesperson to Hold Webinar on Banking Stem Cells at Birth LAS VEGAS, June 16, 2010 -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI) is pleased to announce that Natalie Curry, the Company's official spokesperson and medically saved by the first umbilical cord blood collection in the world, will discuss a wide range of topics about cord blood banking live from CBAI's laboratory in Las Vegas. The live Webinar will occur at 3 p.m. Pacific (6 p.m. Eastern) on Wednesday, June 16, 2010, and can be viewed at http://www.allaboutcordblood.com . Questions can be e-mailed to Ms. Curry before and during the Webinar at [email protected] . "Natalie was diagnosed at age one with Fanconi's Anemia, a rare, but certain to be fatal blood disorder. In 1989, her sister's umbilical cord blood was used in a medical first, a transplant operation that saved her life," said Matthew Schissler, Cord Blood America CEO and co-founder. "Additional information about this event, and the importance of saving umbilical cord blood stem cells at birth, is available at http://www.nataliecurry.com/ . "We believe the more people know about the life saving potential of stem cells, a real life biological insurance policy, the more likely they are to make the correct decision to store their babies' umbilical cord blood stem cells at birth. We have asked Natalie to hold Webinars, to blog and to write articles about this important medical advance. We invite everyone to join and hear for themselves, firsthand, the tremendous story of cord blood stem cells," Mr. Schissler said. About Cord Blood America Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: UVFT - UV Flu Technologies, Inc.) LATEST NEWS!! UV Flu Technologies Announces Placement of ViraTech UV-400 Air Purifiers at Major Boston Hospitals CENTERVILLE, MA, Jun 16, 2010 -- UV Flu Technologies, Inc. (OTCBB: UVFT) is pleased to announce that the Company's UV-400 units have been in operation at two major Boston Hospitals, New England Baptist Hospital, and with the Division of Infectious Diseases at Massachusetts General Hospital, since April, with ongoing favorable responses and excellent feedback. New England Baptist Hospital (NEBH) is an adult care medical/surgical hospital specializing in orthopedic care and complex orthopedic procedures. NEBH is an international leader in the treatment of all forms of musculoskeletal disorders and disease. Massachusetts General Hospital (Mass General or MGH) is a teaching hospital of Harvard Medical School and a biomedical research facility. It is ranked as one of the top five hospitals in the United States. "These are two of the finest medical institutions in the world today," said Bill Fegley, President of Puravair, the distributor responsible for the introduction of the ViraTech UV-400 to the Boston medical market. He further stated, "Hospitals generally look for ways to stay ahead of the curve regarding the safety of their patients and staff. These two particular hospitals are well known for their proactive approach in this area. Given the UV-400's FDA clearance rating and lab test results which prove the unit kills over 99% of bacteria with every pass, how could any hospital not want to evaluate these units? We are thrilled with the feedback we're getting from both hospitals, both of which have stated that the hospital staff is noticing less coughing and respiratory symptoms within the first week of operation of the ViraTech units." The Company plans to announce delivery and commercial availability of the newly updated product shortly. Those interested in the product, or wishing to pre-order are invited to contact the distributor, Puravair LLC, at 1-866-6-PURAVAIR or by email at [email protected]. Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. About UV Flu Technologies, Inc. (OTCBB: UVFT) UV Flu Technologies is an innovative developer, manufacturer and distributor of biotechnology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: BONU - BioNeutral Group, Inc.) LATEST NEWS!! BioNeutral Group Collaborating with Steri-7 (TM) on Product Distribution NEWARK, N.J., Jun 16, 2010 -- BioNeutral Group, Inc. (OTCBB: BONU), a specialty chemical technology-based life science company, announced today that in collaboration with Steri-7(TM), a UK-based specialty chemical health care company, it will be expanding availability of its sporicidal formulations in the UK, Europe and the Middle East. Steri-7(TM) recently obtained approval from the UK's National Health Service (NHS) to market its formulations as a sporicidal cleaner/wipe. BioNeutral has concluded testing for an application to the Environmental Protection Agency (EPA). If and when received, BioNeutral anticipates this approval will facilitate entry into the North American and South American markets as well as complementary markets worldwide. Steri-7(TM) now has over 20 distributors within the broader healthcare market. In May 2010, BioNeutral entered into a non-binding Head of Terms letter setting forth a plan to acquire all of the shares of Steri-7(TM). The acquisition is subject to negotiation of a definitive acquisition agreement, satisfactory completion of due diligence, completion of a specified financing transaction by BioNeutral, and other customary terms and conditions. Terms and conditions are being held confidential pending execution of a definitive agreement. James Fraser, Chief Executive Officer of Steri-7(TM), said, "It has taken two years to meet all of the exhaustive test requirements for NHS approval as a sporicidal cleaner/wipe to help eliminate MRSA, C. difficile, and other dangerous and life-threatening healthcare-acquired infections. Approval by the NHS (approval #VJT 183, 184, 185) is essential for distribution throughout the healthcare sector, including hospitals and nursing homes, in the UK, as is EPA approval in the US. We believe a combined BioNeutral/Steri-7(TM) product line will meet the requirements in all major markets around the world." Mr. Fraser continued, "Steri-7(TM) has been approved by the Air Ambulance Service, and our company has recently received ISO 13485 approval status, which represents the highest standard set by the International Organization for Standardization. Only products made to this level may use the CE mark for surgical instrument cleaners that facilitates entry to European countries." Nick Sayer, Worldwide Director of Sales and Marketing for Steri-7(TM), added, "To my knowledge, there is no other approved product that both addresses difficult-to-kill spores such as C. difficile and is approved by the NHS. The high-level disinfection wipes market is quickly growing in the UK and Europe and is estimated at 100 million pounds per year." About BioNeutral Group, Inc. Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a specialty chemical technology-based life science company that is developing and intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous microorganisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), are both eco-friendly. The Company has combined these widely used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene(TM) brand have not yet been submitted to the EPA for approval for sale in the United States; however they have been approved in Germany and are allowed in the UK, France and Sweden. More information about the Company may be found at www.bioneutralgroup.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: DTRO - Deltron, Inc.) LATEST NEWS!! Deltron's Manufacturing Subsidiary Offers Proprietary Sustainable Soy-Based Polyurethanes that Meet Customer Requirements & Reduce Carbon Footprint GARDEN GROVE, Calif., Jun 16, 2010 -- Deltron, Inc. (OTCBB: DTRO) is pleased to announce that wholly owned manufacturing subsidiary Elasco, Inc. has developed proprietary polyurethane formulations made from renewable resources that significantly reduce the carbon footprint of manufactured products. Deltron's Elasco offers polyurethane produced from renewable soybean oil as an alternative to conventional polyurethane made from petroleum-based chemicals. The company is finding a growing market for its green formulations. Deltron's wholly owned Elasco subsidiary is a profitable engineered plastics and polyurethane molding and manufacturing company. Elasco has been in business since 1979 and has a highly efficient production facility in Southern California. The company provides complete design and manufacturing services including prototype work, mold and tooling design, manufacturing, custom casting, plastic injection molding and proprietary polymer mixing. Leveraging 31 years of experience in polyurethane formulation for diverse industries, Elasco has developed sustainable, energy efficient polyurethane formulations made with renewable plant-based raw materials. The company combines polyols produced from pressed soybeans with isocyanate to create new polymers that meet customer specifications. Traditional polyurethane products are made entirely from petrochemicals. Soy-based polyol resins used in Elasco's polyurethanes reduce related carbon emissions from the manufacturing process by 36%, require less energy to produce, use sustainable materials, are free of volatile organic compounds (VOCs), and reduce demand for and reliance on non-renewable petroleum reserves. Henry Larrucea, Deltron CEO, commented: "Deltron is proud to be able to offer our customers environmentally friendly alternatives that have all the performance, versatility and durability of hydrocarbon-based polyurethane with significantly less environmental impact. Our team has been developing and selling polyurethane products containing soy-based polyols for two years. We are seeing increased demand for 'greener' products from customers, particularly those in the recreational products industry, and believe Deltron will be able to significantly expand sales in this arena." About Deltron, Inc. Deltron acquires profitable businesses with strong management teams, substantial revenue and established market positions. Wholly owned division Blu Vu is a developer of proprietary closed circuit rebreather technology and components that go beyond conventional breathing systems to enable commercial and recreational divers to go deeper, stay underwater longer and recover faster. Wholly owned Elasco is a proven innovator in product manufacturing with a 30-year operating history, diverse customer base and vertically integrated manufacturing facility in Garden Grove, California. ------------------------------------------------------------------------------------------------------------------------------------------------------------ About StockMarketingInc.com StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed. ((Comments on this story may be sent to [email protected])) (c) 2010 M2 COMMUNICATIONS |